CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
7500-55-2 | | 4-cyclohexene-1,2-dicarboxylic acid, dimethyl ester | | | | |
7500-66-5 | | 1-benzoyl-1-bromocyclohexane | | | | |
7500-71-2 | | 2-(1-hydroxyamino-2,2,2-trichloroethyl)-acetoacetic aci ethyl ester | | | | |
7500-76-7 | | 1,1'-(phenylmethylene)bis(4-methoxy-benzen | | | | |
7500-82-5 | | diallyl ester, (e)-cyclohexane-2-dicarboxylic acid | | | | |
7500-86-9 | | 2,4,6-trinitro-benzoyl chlorid | | | | |
7500-98-3 | | n-acetyl-n'-propionyl-1,4-phenylenediamine | | | | |
75001-30-8 | 6-溴咪唑并[2,1-b]噻唑 | 6-bromoimidazo[2,1-b]thiazole | | | | |
75001-31-9 | 2-(二乙胺基)-1,3-噻唑甲醛 | 6-methyl-imidazo[2,1-b]thiazole-5-carbaldehyde | | | | |
75001-47-7 | | n-(5-amino-2-fluorophenyl)acetamide | | | | |
75001-63-7 | 诺氟沙星杂质12 | norfloxacin impurity 12 | | | | |
75001-77-3 | 诺氟沙星ep杂质b | norfloxacin ep impurity b | | | | |
75001-78-4 | 诺氟沙星ep杂质e | norfloxacin ep impurity e | | | | |
75001-82-0 | 诺氟沙星ep杂质d | norfloxacin ep impurity d | | | | |
75002-98-1 | | 2-bromo-6-chlorobenzyl bromide | | | | |
75004-32-9 | | cyclohexyl n-(3-nitrophenyl)carbamate | | | | |
75005-50-4 | | 2-hydroxyestradiol 17-sulfate | | | | |
75005-71-9 | | 5-methyl-1- oxobutyl)amino)-1-(4-carboxy-3-dihydro-2-oxo-1h-imidazol-1-yl)-1 | | | | |
75005-95-7 | | 2-ethylhexyl 2-(4-phenylbenzoyl)benzoate | | | | |
75006-64-3 | | dimethylglyoxime disodium salt octahydrate | C4H8N2O2 | 116.11 | 300℃ | |
75007-09-9 | | methyl 6,8-dideoxy-7-o-methyl-6-(((1-d-erythro-alpha-d-galacto-octopyranosid | | | | |
75007-13-5 | | diphenyliodoniumperchlorate | | | | |
75007-31-7 | | 4-(2-(3,5-dimethyl-1-pyrazolyl)-4-thiazolyl)-pyrocatecho | | | | |
75007-32-8 | | 2-(3,5-dimethyl-1-pyrazolyl)-4-methyl-thiazol | | | | |
75007-33-9 | | 2-(3,5-dimethyl-1-pyrazolyl)-4-phenyl-thiazol | | | | |
75007-70-4 | 拉氧头孢杂质1 | latamoxef impurity 1 | | | | |
75009-88-0 | 甲硅烷基封端的聚醚(KANEKA MS聚合物S203H) | Silyl-terminated polyether (Kaneka MS Polymer S203H) | (C3H6O)nC12H30O5Si2 | | | |
7501-02-2 | | 2-(o-biphenylyloxy)-ethano | C14H14O2 | 214.26 | | |
7501-09-9 | | 3-allyl-4-methoxybenzoic acid | | | | |
7501-29-3 | | (1,2,5)thiadiazolo(3,4-d)pyrimidine-5,7(4h,6h)-dione | | | | |
7501-37-3 | 4-(4-异丙基苯基)丁酸 | 4-(4-isopropylphenyl)butyric acid | | | | |
7501-62-4 | | 4-(1,3-benzodioxol-5-ylcarbonothioyl)morpholine | C12H13NO3S | 251.30 | | |
7501-72-6 | | 2,4-diamino-6-styryl-s-triazin | | | | |
75011-65-3 | | propanoic acid, 2-methyl-, 4-(2-(methylamino)ethyl)-1,2-phenylene ester, hydroc | | | | |
75013-45-5 | | pyrocatechol, 4-(2-(3-methyl-5-(1,1,2,2-tetrafluoroethyl)-1-pyrazolyl)-4-thiazo | | | | |
75013-64-8 | | ketone, methyl 2-pyridyl, 4-methyl-3-thiosemicarbazone | | | | |
75013-66-0 | | ketone, methyl 2-pyridyl, 4-butyl-3-thiosemicarbazone | | | | |
75013-78-4 | | 1-propanone, 1-(2-pyridyl)-, 4,4-dimethyl-3-thiosemicarbazide | | | | |
75013-85-3 | | ketone, methyl 2-pyridyl, 4-phenylsemicarbazone | | | | |
75016-34-1 | | n-methyl-n-nitroso-butylamine-1-d(sup 2) | | | | |
75016-36-3 | | n-methyl-d(sup 3)-n-nitroso-butylamin | | | | |
75017-17-3 | | (3,3-dimethylcyclobutyl)methanol | | | | |
75017-25-3 | | 4h-(1,4)oxazino(4,3-a)(1,4)benzodiazepine, 1,2,4a,5-tetrahydro-9-chloro-7-pheny | | | | |
75017-27-5 | | 4h-(1,4)oxazino(4,3-a)(1,4)benzodiazepine, 1,2,4a,5-tetrahydro-9-fluoro-7-pheny | | | | |
75017-30-0 | | 4h-(1,4)oxazino(4,3-a)(1,4)benzodiazepine, 1,2,4a,5-tetrahydro-9-methyl-7-pheny | | | | |
75017-31-1 | | 4h-(1,4)oxazino(4,3-a)(1,4)benzodiazepine, 1,2,4a,5-tetrahydro-10-methyl-7-phen | | | | |
75017-39-9 | | 4h-(1,4)oxazino(4,3-a)(1,4)benzodiazepine, 1,2,4a,5-tetrahydro-9-chloro-7-(2-ch | | | | |
75017-41-3 | | 4h-(1,4)thiazino(4,3-a)(1,4)benzodiazepine, 1,2,4a,5-tetrahydro-9-chloro-7-phen | | | | |
75017-65-1 | | pyrazino(1,2-a)(1,4)benzodiazepine, 1,2,3,4,4a,5-hexahydro-9-chloro-3-(2-propen | | | | |
75017-70-8 | | pyrazino(1,2-a)(1,4)benzodiazepine, 1,2,3,4,4a,5-hexahydro-3,9-dimethyl-7-pheny | | | | |